Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma
Abstract Background The incidence of stage I and stage II lung adenocarcinoma (LUAD) is likely to increase with the introduction of annual screening programs for high-risk individuals. We aimed to identify a reliable prognostic signature with immune-related genes that can predict prognosis and help...
Main Authors: | Pancheng Wu, Yi Zheng, Yanyu Wang, Yadong Wang, Naixin Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-020-02545-z |
Similar Items
-
A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)
by: Aisha Al-Dherasi, et al.
Published: (2021-06-01) -
A four-gene prognostic signature for predicting the overall survival of patients with lung adenocarcinoma
by: Lei Liu, et al.
Published: (2021-09-01) -
Establishment of a Gene Signature to Predict Prognosis for Patients with Lung Adenocarcinoma
by: Zhaodong Li, et al.
Published: (2020-11-01) -
An individualized immune prognostic signature in lung adenocarcinoma
by: Liangdong Sun, et al.
Published: (2020-05-01) -
Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
by: Guomin Wu, et al.
Published: (2021-07-01)